Litcius/Paper detail

Endoscopic vs. microscopic transsphenoidal pituitary surgery: a single centre study

Morten Winkler Møller, Marianne Andersen, Dorte Glintborg, Christian Bonde Pedersen, Bo Halle, Bjarne Winther Kristensen, Frantz Rom Poulsen

2020Scientific Reports52 citationsDOIOpen Access PDF

Abstract

Endoscopic pituitary surgery has shown promising results. This study reports the experiences of experienced microscopic pituitary surgeons changing to the endoscopic technique, and the beneficial effects on the postoperative outcomes. 45 transsphenoidal endoscopic-assisted surgeries performed in 2016-2017 were compared with 195 microscope-assisted surgeries performed in 2007-2017 for pituitary adenoma. Tumour size, hormonal status and vision were assessed preoperatively and 3-5 months postoperatively. Cases were identified through electronic patient records. GTR was achieved in 39% of the endoscopic operations vs. 22% of microscopic operations, p = 0.018. Mean duration of surgery was 86 min (77-95) with the endoscopic technique vs. 106 min (101-111) with the microscopic technique, p < 0.001. New hypothalamus-pituitary-adrenal axis deficiencies were observed after 3% of endoscopic vs. 34% microscopic operations, p = 0.001, and overall fewer postoperative pituitary deficiencies were observed in the endoscope-assisted group. Complications within 30 days of surgery occurred in 17% of endoscopic operations vs. 27% of microscopic operations (p > 0.05). Normalization of visual impairment occurred in 37% of the cases with preoperative visual impairment in the endoscopic group vs. 35% of those in the microscopic group (p > 0.05). The endoscopic technique performed better as a surgical procedure for pituitary adenomas. We found no statistically significant differences in complication rate or visual improvement between the two techniques.

Topics & Concepts

Transsphenoidal surgeryEndoscopic surgeryMedicineEndoscopySurgeryPituitary adenomaPathologyAdenomaPituitary Gland Disorders and TreatmentsGrowth Hormone and Insulin-like Growth FactorsMeningioma and schwannoma management